alphaveORCHPHARMA₹1,010.00

Orchid Pharma Limited

₹ CrorePeersFDC GUJTHEM IOLCP MOREPENLAB RPGLIFE GUFICBIO INNOVACAP UNICHEMLABMcap ₹5,123 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	618.9	631.6	613.2	613.2
+ Capital Work-in-Progress	16.4	64.5	340.5	340.5
+ Goodwill	0.0	1.1	0.0	0.0
+ Other Intangibles	0.6	0.0	0.6	0.6
+ Intangibles under Development	14.3	16.2	73.1	73.1
+ Non-current Investments	45.8	49.7	52.7	52.7
+ Other Non-current Financial Assets	6.0	4.3	142.0	142.0
Non-current Financial Assets	51.8	53.9	194.7	194.7
+ Deferred Tax Assets	51.3	51.3	—	—
+ Other Non-current Assets	9.8	61.8	4.9	4.9
Total Non-current Assets	763.1	880.5	1,227.0	1,227.0
Current Assets
+ Inventories	264.2	326.4	256.4	256.4
+ Trade Receivables	195.5	241.8	263.9	263.9
+ Cash & Cash Equivalents	3.6	21.1	7.0	7.0
+ Other Bank Balances	263.0	158.5	76.2	76.2
+ Other Current Financial Assets	4.5	3.0	0.9	0.9
Current Financial Assets	466.6	424.5	347.9	347.9
+ Other Current Assets	58.3	53.8	76.7	76.7
Total Current Assets	790.8	807.4	683.6	683.6
Total Assets	1,553.9	1,687.9	1,910.9	1,910.9
Equity
+ Equity Share Capital	50.7	50.7	50.7	50.7
+ Other Equity / Reserves	1,118.7	1,216.6	1,237.1	1,237.1
Equity — Owners of Parent	1,169.5	1,267.3	1,287.8	1,287.8
Total Equity	1,169.5	1,267.3	1,287.8	1,287.8
Liabilities
+ Borrowings — Non-current	120.4	131.6	327.7	327.7
+ Other Non-current Financial Liab	—	0.0	4.7	4.7
Non-current Financial Liabilities	120.4	131.6	332.5	332.5
+ Provisions — Non-current	3.6	3.4	11.7	11.7
+ Other Non-current Liabilities	0.4	0.0	—	—
Non-current Liabilities	124.4	135.1	344.2	344.2
+ Borrowings — Current	14.0	42.6	29.8	29.8
+ Trade Payables	229.6	222.1	229.9	229.9
+ Other Current Financial Liab	—	0.0	0.4	0.4
Current Financial Liabilities	243.6	264.7	260.0	260.0
+ Provisions — Current	2.1	2.4	0.1	0.1
+ Other Current Liabilities	14.3	18.5	18.8	18.8
Current Liabilities	260.0	285.6	279.0	279.0
Total Liabilities	384.4	420.6	623.1	623.1
Total Equity & Liabilities	1,553.9	1,687.9	1,910.9	1,910.9
Assets — additional as-filed lines
+ Current Tax Assets	1.6	2.8	2.6	2.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	11.0	4.4	4.4
+ Dues to Other Creditors — Current	—	211.1	225.6	225.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.